Viewing Study NCT04207918


Ignite Creation Date: 2025-12-25 @ 4:56 AM
Ignite Modification Date: 2025-12-26 @ 3:56 AM
Study NCT ID: NCT04207918
Status: COMPLETED
Last Update Posted: 2024-05-16
First Post: 2019-12-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module